Improving the outcomes of children with cancer

Press Office

Susanne Barkmann

Phone+49 (0)40-426051212
Mobile+49 (0)173-6276993
E-mailbarkmann@remove-this.kinderkrebs-forschung.de

News

This year, the Schüller group was represented by five scientists at the most important international meeting on neuro-oncology. After cancelling in 2020, the latest research results could be presented and discussed in presence again. Prominent topics of the meeting were developments in immunooncology, single cell sequencing and cancer neuroscience. The trip was partly supported by the Fördergemeinschaft Kinderkrebs-Zentrum Hamburg. Ulrich Schüller and his team presented their research...

Bürgermeister Dr. Peter Tschentscher zu Gast im Forschungsinstitut Kinderkrebs-Zentrum Hamburg

The infiltration of tumor infiltrating lymphocytes (TILS) into a tumor allows statements on the immune response as well as prognoses on therapy success and survival outcomes. In order to make this biomarker more useful for childhood brain tumors, a practical technique that is oriented towards diagnostic routine has been lacking until now. With DIMEimmune, Professor Schüller's research team has now developed an analysis tool that can be applied to DNA methylation data and derive statements about...

The Research Institute Children's Cancer Center Hamburg was founded 15 years ago with the goal of better understanding the molecular basis of childhood cancer development and paving the way for new therapies. Today, around 50 employees, physicians, scientists and technical assistants work in the field of stem cell transplantation and immunotherapy, leukemias as well as pediatric neuro-oncology - in other words, they conduct research on topics that play a central role in pediatric oncology. The...

Interview mit Hirntumorforscher Professor Dr. Ulrich Schüller anlässlich des Welthirntumortags am 8. Juni 2021

Juli-Harnack-scholarship for medical postgraduate students in the field of pediatric onkology

New insights into the development of ALL - the most common type of cancer in childhood.

Clinically and molecularly distinct subgroup discovered within the group of atypical teratoid / rhabdoid tumors